Drugs / sulphadoxine-pyrimethamine
Trials 11 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03208179 Comparator | Mar 2018 → Mar 2020 | malaria, pregnancy disorder | Liverpool School of Tropical Medicine | Completed | No outcome recorded |
| Phase 3 | NCT01053325 Comparator | Sep 2010 → Dec 2012 | HIV infectious disease, malaria | Institute of Tropical Medicine, Belgium | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00285662 Comparator | Jun 2006 → May 2010 | anemia, malaria | Papua New Guinea Institute of Medical Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulphadoxine-pyrimethamine | “The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria” NCT02758353 ↗13“Intermittent preventive treatment with sulphadoxine-pyrimethamine” NCT01053325 ↗ |
| Known as | sulfadoxine-pyrimethamine | “The use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) is threatened by the spread of resistance to SP.” PMID 18752443 ↗ Oct 20081“sulfadoxine-pyrimethamine (SP) (25 mg/kg and 1.25 mg/kg) plus amodiaquine (AQ) (10 mg/kg, 3 d, n = 374)” PMID 22479155 ↗ Mar 2012 |
| Modality | Small molecule | “Sulphadoxine-pyrimethamine (SP) is a fixed combination of a long-acting sulfonamide and the antifolate pyrimethamine.” NCT01707199 ↗ |